© Copyright Acquisition International 2026 - All Rights Reserved.

Article Image - OPKO Health Acquires EirGen Pharma
Posted 28th May 2015

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

View Biography
Image

Paul Heffernan, Legal Adviser OPKO Health

OPKO Health, Inc. is pleased to announce the acquisition of EirGen Pharma, Ltd., a growing, profitable and cash flow positive specialty pharmaceutical company focused on the development and commercial supply of high potency, high barrier to entry, pharmaceutical products for sale in the U.S., Canada, Japan, Australia, most European countries, and more than 40 others around the world.

EirGen, based in Waterford, Ireland, was founded by two former executives of IVAX Pharmaceuticals, Tom Brennan and Patsy Carney. The company, situated in a state of the art high containment research and development, and manufacturing facility, is approved by the FDA, EMEA (European Health Authorities) and the PMDA (Japanese Health Authorities). High potency drugs such as those used for cancer chemotherapy are typically unsuitable for manufacture in normal multi-product facilities due to cross contamination risks.

To date, EirGen and its commercial partners have filed 10 product applications with the FDA and 5 each in Europe and Japan. EirGen has a strong research and development portfolio of over 20 niche, high barrier to entry drugs and, with access to additional capital that OPKO will provide, together with the benefits of Irish government programs to encourage research and development in Ireland, EirGen will rapidly expand its drug portfolio.

“EirGen Pharma is one of the leading developers and suppliers of high potency niche pharmaceutical products in the world,” said Phillip Frost, M.D. OPKO’s Chairman and CEO. “As FineTech, OPKO’s Israeli active pharmaceutical ingredient manufacturing subsidiary, is also focused on high potency drugs, an immediate business synergy is expected. EirGen also offers the significant benefit of potentially being able to manufacture OPKO’s current and future products in our own facilities, which we expect will result in even higher gross margins. The superb management, research and development, manufacturing and product distribution teams, along with state of the art facilities, together, will create an important, tax efficient base of operations for OPKO,” said Dr. Frost.

Categories: M&A, Strategy


You Might Also Like
Read Full PostRead - Eye Icon
Top Reasons to Invest in PMO Software for Your Business
News
27/05/2024Top Reasons to Invest in PMO Software for Your Business

Project management office (PMO) software provides a central system to align project goals with business strategy. It makes sure that projects are finished not just on time and within budget but also perfectly match up with the objectives of any company. This s

Read Full PostRead - Eye Icon
The Golden Age of Digital Experience Monitoring
Innovation
24/12/2020The Golden Age of Digital Experience Monitoring

In the midst of a pandemic, using cloud-based technology such as Microsoft 365 has proven vital for employees to stay productive. In October 2020, Microsoft reported 115 million daily active users of Teams. This is where Martello Technologies comes in, offerin

Read Full PostRead - Eye Icon
Stylish Café Is Home To Tempting Treats
News
26/03/2021Stylish Café Is Home To Tempting Treats

A small café that has made itself a thriving part of a vibrant local ecosystem, Temptations is a community favourite for both its menu and its attitude. We unearth the luxury of this local watering hole that has earned the title of Most Outstanding Café, 202

Read Full PostRead - Eye Icon
What Is a Partition Action in Business Property?
M&A
21/04/2026What Is a Partition Action in Business Property?

A partition action in business property is a court-ordered process used to divide or sell real estate when co-owners cannot agree on its management or disposal. It serves as the final legal exit strategy for business partners, investors, or LLC members who are

Read Full PostRead - Eye Icon
5 Resources to Help You Find a Knowledgeable Personal Injury Lawyer in Atlanta
Legal
13/05/20245 Resources to Help You Find a Knowledgeable Personal Injury Lawyer in Atlanta

After an incident, the aftermath entails stress and chaos. If involved in a car accident, for example, you’re already dealing with injuries, damage to your automobile, and intricacies involved.

Read Full PostRead - Eye Icon
Resolving Franchising Disputes in the UK
Finance
29/02/2016Resolving Franchising Disputes in the UK

Franchising is the granting of a license by a franchisor to a franchisee, which entitles the franchisee to operate their own business using the franchisor’s brand, systems, knowhow and business model.

Read Full PostRead - Eye Icon
The Return of Inflation
Finance
15/09/2015The Return of Inflation

The key figure within the recent inflation data was not the headline of the Consumer Price Index (CPI) rate, but instead, the surprise jump in core inflation was an eye opener this time around.

Read Full PostRead - Eye Icon
Furlough Scheme Extension – the Good, the Bad and the Ugly Cost
Finance
11/11/2020Furlough Scheme Extension – the Good, the Bad and the Ugly Cost

Shaw & Co, the Bristol-based specialist corporate finance advisory firm, has responded to the announcement made by Rishi Sunak, Chancellor of the Exchequer, on Thursday 5 November in the House of Commons announcing the extension of the UK Furlough Scheme.

Read Full PostRead - Eye Icon
How Doing Less Can Drive More Impact for Bootstrapped AI Businesses
News
24/03/2026How Doing Less Can Drive More Impact for Bootstrapped AI Businesses

In technology, scale is often treated as the ultimate proof of success. More customers, broader functionality, more potential. Growth is the primary goal. But for bootstrapped AI companies, that drive to do everything more often than not becomes a limitation.



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow